A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...
Benjamin Netanyahu’s early prostate cancer diagnosis and successful treatment underline how routine checkups can lead to ...
Syncromune is advancing SYNC-T Therapy SV-102 in the ongoing Phase 2 LEGION-100 study (NCT06533644), which is actively enrolling across multiple sites in the U.S. Please visit www.legion100trial.com ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with ...
Sir Chris Hoy has provided an update on his stage four prostate cancer diagnosis after doctors initially warned he had just ...
A simple blood test can reveal the geographic relationships among healthy cells surrounding a cancerous tumor, researchers at ...
The leader of Israel called the situation a "minor medical issue." Doctors say the disease often grows slowly.
Many cancer patients turn to biotin supplements hoping to restore hair lost during treatment, but experts warn the popular ...
Sir Chris Hoy, the Olympic cycling champion diagnosed with stage four prostate cancer in 2023, has provided a health update, ...
Legendary British Olympian Sir Chris Hoy has shared an update about his health nearly three years after he was diagnosed with stage 4 cancer ...
Three separate announcements revealed advancements in oncology: FDA clearance for ArteraAI Breast, a GSK-Halozyme agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results